Pure Global

Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test - India CDSCO Medical Device Registration

Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000341_693446b6ba101238a032e2307abf70e1_8f925df88629c38dfd40ef27e49833c9. This device is marketed under the brand name Cellex. The license holder is Inbios India, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test
UID: IMP/IVD/2020/000341_693446b6ba101238a032e2307abf70e1_8f925df88629c38dfd40ef27e49833c9

Brand Name

Cellex

License Holder

Inbios India

Device Class

Class C

Approving Authority

CDSCO

Product Information

The Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test is a lateral flow immunoassay for qualitative detection of antibodies to 2019 novel coronavirus (Cellex) in serumใ€ plasma or whole blood specimens.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Similar Products (1)
Other products with the same name or brand